🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

VIH : traiter au plus tôt pour mieux contrôler le virus lemonde.fr/sciences/artic…

New immune cell engagers for cancer immunotherapy | Nature Reviews Immunology nature.com/articles/s4157…

Release of 8 new genomes of a new lineage of SARS-CoV-2 with > 100 mutations from South Africa. This is probably the most divergence lineage identified this year. In this thread, we highlight some of the characteristics of the new BA.2.X lineage and epidemiology in SA.

Ce matin j'étais dans la matinale de France Inter pour parler sciences et féminisme avec Ali Baddou, Marion L'Hour et A. Palt Plus de diversité pour une meilleure science au service de toutes et tous ! ✊🦠🧬👩‍🔬👩‍🚀👩‍💻 radiofrance.fr/franceinter/po…

rdcu.be/dA36H The alternation between ‘classic’ and surprising periods of evolution of SARS-CoV-2 continues, and we studied a recent panel of variants with large diffusion worldwide, including JN.1!

See our analysis of the fusion, fitness and immune evasion properties of 9 recent #SARSCoV2 variants, including JN.1 Congrats to Planas Delphine Etienne Simon-Loriere and colleagues! rdcu.be/dA6UN

Depuis 30 ans, face au VIH, on n’a pas arrêté de s’aimer, de pleurer, de chercher, de demander, de progresser... Aujourd’hui, nous n’avons pas le droit d’arrêter. Continuons le combat. Faites un don. #Sidaction2024 Merci ❤️ à #MyleneFarmer pour la 🎙️ et WOODKID pour la 🎶

Explore #HIVResearch #SARS-CoV-2 and other emerging #Virus with field leaders@KeystoneSymp now in #hannover ! keystonesymposia.org/conferences/co…

Yesterday, at the International AIDS Conference (#AIDS2024) in Munich, we got one of those thrilling moments you hope for when attending a scientific conference -- but don't usually get! Here's what happened. Linda-Gail Bekker Moupali Das, MD, MPH blogs.jwatch.org/hiv-id-observa…

Escape of #SARS-CoV-2 KP1.1, LB.1 and KP3.3 from recently approved monoclonal antibodies. #Pemivibart/VYD222 is less efficient, #Sipavibart/ AZD3152 no longer neutralizes KP1.1, LB.1, and KP3.3 in cell systems. Congrats to Planas Delphine and coll.! biorxiv.org/content/10.110…

Spatial omics have lit up life science and this new review Cell is the best I've seen cell.com/cell/fulltext/… open-access

#PressRelease 📰 Researchers Institut Pasteur, since 1887 have developed artificial “lymphoid organ-chips” that recreate much of the human immune system’s response to booster #vaccines. See our news release ➡️ hubs.la/Q02NYGf30 Original paper ➡️ hubs.la/Q02NYFWC0 @Team_Chakra

Jeger-Madiot et al. @Team_Chakra Institut Pasteur, since 1887 developed a lymphoid organ-chip that models human recall responses to protein and mRNA vaccination. hubs.la/Q02NZnQv0 #COVID #Vaccines

Delighted to see this out: combining mathematical modeling and the data of the ANRS Maladies infectieuses émergentes SIV controllers study to elucidate the role of CD8 T-cells in natural control of infection. Great work led by Bharadwaj Vemparala, Jeremie Guedj and Narendra Dixit journals.plos.org/ploscompbiol/a…

Escape of #SARS-CoV-2 KP1.1, LB.1 and KP3.3 from recently approved monoclonal antibodies. #Pemivibart/VYD222 is less efficient, #Sipavibart/ AZD3152 no longer neutralizes KP1.1, LB.1, and KP3.3 in cells. Congrats to Planas Delphine et al! Pathogens & Immunity paijournal.com/index.php/paij…

Check out our latest results published in Lancet ID on genotypic and phenotypic characterisation of RSV after nirsevimab breakthrough infections. Thanks @ french virology network ANRS ANRS Maladies infectieuses émergentes , @ Marie-anne Rameix Welti, UPEC Inserm presse.inserm.fr/en/resistance-…

Very happy to see our article now available on JID: “Compartmentalized HIV-1 reservoir in intestinal monocytes/macrophages on ART” with the support of ANRS Maladies infectieuses émergentes (EP61 GALT) and Sidaction Infinity Toulouse CHU de Toulouse - compte inactif UT3 Paul Sabatier #HIV #macrophages #gut #HIVreservoir

To get 2025 off to a good start, I'm delighted to share with you our study published today in Nature Microbiology 🎉 We studied the ability of the receptor-binding proteins (RBP) of >100 animal viruses to mediate entry into human cells. A short thread below. nature.com/articles/s4156…

🚨 New preprint alert 🚨 We searched for the presence of coronaviruses in >200 bat individuals across Spain 🦠🦇🇪🇸. We recovered 6 complete coronavirus genomes, including 3 novel species. One of them could use bat and human ACE2 for entry. biorxiv.org/content/10.110…

🚨 Preprint alter - bis 🚨 I am thrilled to share our last preprint where we identify and characterize a new coronavirus receptor! 🦠 This work was done in collaboration with the team of Félix Rey @virusfusion007 at the Institut Pasteur. A 🧶 below... biorxiv.org/content/10.110…